Polar Asset Management Partners’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-16,958
| Closed | -$304K | – | 668 |
|
|
2025
Q1 | $304K | Buy |
+16,958
| New | +$304K | 0.01% | 301 |
|
|
2023
Q3 | – | Sell |
-230,965
| Closed | -$3.55M | – | 957 |
|
|
2023
Q2 | $3.55M | Sell |
230,965
-567,225
| -71% | -$8.71M | 0.06% | 353 |
|
|
2023
Q1 | $18M | Buy |
798,190
+480,900
| +152% | +$10.8M | 0.27% | 77 |
|
|
2022
Q4 | $6.67M | Sell |
317,290
-25,000
| -7% | -$526K | 0.08% | 306 |
|
|
2022
Q3 | $8.43M | Sell |
342,290
-240,410
| -41% | -$5.92M | 0.1% | 293 |
|
|
2022
Q2 | $14.1M | Buy |
582,700
+491,500
| +539% | +$11.9M | 0.16% | 158 |
|
|
2022
Q1 | $2.35M | Buy |
+91,200
| New | +$2.35M | 0.03% | 576 |
|
|
2021
Q4 | – | Sell |
-257,500
| Closed | -$6.24M | – | 1451 |
|
|
2021
Q3 | $6.24M | Buy |
+257,500
| New | +$6.24M | 0.06% | 309 |
|